跳至主要内容
临床试验/NCT02932553
NCT02932553撤回4 期

BVS Implantation in Patients With Variant Angina and MODerate Coronary Artery Disease: Pilot Study

Seung-Jung Park1 个研究点 分布在 1 个国家开始时间: 2017年4月19日最近更新:
适应症

试验速览

阶段
4 期
状态
撤回
发起方
试验地点
1
主要终点
Composite of all cause death, myocardial infarction, and angina-related hospitalization

研究概览

简要总结

The purpose of this study is to determine whether BVS(Bioresorbable Vascular Scaffold) implantation with optimal medical therapy can improve the outcome of patients with variant angina and moderate coronary artery disease.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 19 and more
  • Vasospastic angina diagnosed by provocation test including ergonovine provocation coronary angiography or ergonovine echocardiogram
  • No-ischemia producing moderate coronary artery disease(stenosis>50%, FFR>0.8)

排除标准

  • Ischemic coronary lesion
  • Organic heart disease associated with myocardial ischemia or sudden cardiac death
  • History of percutaneous coronary intervention
  • Cerebrovascular diseases or peripheral disease
  • NYHA III and IV
  • Cardiac pacemaker or implantable defibrillator
  • Pregnancy or breast feeding
  • Life expectancy less than 2 years

结局指标

主要结局

Composite of all cause death, myocardial infarction, and angina-related hospitalization

时间窗: 2year

次要结局

  • Cardiac death(2year)
  • Angina-related hospitalization(2year)
  • All cause death(2year)
  • Variant angina(2year)
  • Scaffold thrombosis(2year)
  • Repeat revascularization(2year)
  • Myocardial infarction(2year)
  • Composite event of death or myocardial infarction(2year)
  • Stroke(2year)
  • Composite event of cardiac death or myocardial infarction(2year)

研究者

发起方
Seung-Jung Park
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Seung-Jung Park

professor, Division of Cardiology, Department of Internal Medicine

Asan Medical Center

研究点 (1)

Loading locations...

相似试验